November 19, 2026
Dietary supplements containing traditional herbal preparations that have been safely used long before May 15, 1997, face numerous problems under European legislation on novel foods.
Novel food?
A herbal preparation is considered “novel” if it was not consumed to a significant degree in the EU before May 15, 1997, and falls under one of the ten categories listed in Article 3, paragraph 2, point a. For plants, categories 4, 7, and 10 are particularly relevant [1,2]. Category 10 refers to the Food Supplements Directive [3]. This directive was not adopted until 2002, five years after the Novel Foods Regulation [4].
If it is determined that the ingredient is a novel food, it must undergo a 2–3-year approval process by the European Commission (EC) before it can be placed on the market, following a lengthy safety assessment by the European Food Safety Authority (EFSA) based on a comprehensive dossier.
For example, plant extracts are required to undergo analyses to detect the presence of nanoparticles, among other things. This requires a significant investment of time and money for relatively simple cases. For more complex dossiers, involving more in-depth questions from EFSA, the assessment can take up to five years and incur higher costs, with no guarantee of a positive outcome. Such investments are not feasible for small or medium-sized enterprises. This in itself gives a competitive advantage to the major players in the market, who are the only ones able to place their new food products on the market.
The consultation procedure: evidence without certainty
Article 4 states that only if food business operators are unsure whether a food they wish to place on the market falls within the scope of this regulation may they consult the Member State where they intend to place the novel food on the market for the first time. For this consultation procedure, the company must submit a technical dossier containing a detailed description of the food, including the conditions of use, the production process, and an overview of human consumption of the food within the EU before May 15, 1997. The receiving Member State then determines whether the dossier is valid and decides within four months whether a food product is a novel food [5]. The risk of this procedure is that a negative conclusion will be published on the EC’s website, resulting in the ingredient being immediately banned throughout the EU.
Proof of Significant Consumption
To avoid this outcome, companies must therefore demonstrate that their ingredient was already consumed in the EU to a “significant extent” prior to the aforementioned date. This is referred to as a history of use. Such evidence may consist of sales and import invoices, dated labels, a certificate from another Member State, cookbooks, and/or FAO statistics. It is essential that there be a precise description of the plant part or extract used, that it demonstrate EU consumption (not in the U.S., China, or Switzerland), and that it be clearly linked to food. Standalone price lists, catalogs, or pharmacy invoices are often considered insufficient evidence on their own.
This was nearly thirty years ago, in 1997, a time when digital archiving was rare, and computers were just becoming commonplace. Companies that marketed pre-measured food products in the 1980s and 1990s were unaware that they were required to retain import or sales invoices for decades. The evidence is sometimes buried under a layer of dust, has been lost, or is stored on a hard drive that no longer works.
These are often plants from traditional practices in India and China, used in teas or decoctions. That connection is mistakenly interpreted as an indication that these are medicinal products. Eastern therapies, however, have a very broad, holistic view of maintaining health. Nutrition and tea, massage, and exercise are just as much a part of their practice.
Stuck with the authorities
I work with several companies that were founded before 1990 and sell pre-measured herbal powders in the EU. A Dutch company wanted to register supplements in Belgium, but the Belgian authorities refused to evaluate the extensive history of use; they referred the company back to the Dutch authorities. The Dutch authorities threw up their hands and, in turn, also declined responsibility. It’s an administrative game of ping-pong where nobody wins. Well, the SME’s lose.
Another company submitted a notification in 1997, when the Belgian Royal Decree on Plant Preparations took effect in Belgium [6]. For about a decade, no questions were asked about the history of use. Many traditional plants were added to the list of authorized plants following a thorough safety evaluation by the Belgian scientific committee. That is, until around 2010, when the administration changed course. Suddenly, it became mandatory to submit a history of use. The company submitted four boxes of invoices to the government—to no avail. Now, a container holding the same herbal preparations has been stuck in limbo for over a year, with mounting costs and the threat of destruction.
A Ray of Hope
A Danish party submitted a comprehensive list of over 280 traditional plant-based preparations to the authorities, which was subsequently accepted. These plants are not considered “novel” when used in food supplements. However, the assessment is being conducted on a plant-by-plant basis by a single individual, a process that has already dragged on for a year.[7] Recently, it was confirmed that 13 of these plants are not classified as “novel” in the context of food supplements. Nevertheless, they still need to be added to the so-called “Novel Food Catalogue” by the European Commission which can take months still —though it should be noted that this list carries no legal weight.[8]
Conclusion
The 1997 threshold is illogical and has become a virtually insurmountable burden of proof for traditional herbal preparations. Outdated archival material, slow national procedures, inadequate cooperation between member states, and vague criteria are pushing healthy (young and small) companies toward bankruptcy—not because of safety concerns, but due to the administrative red tape. The unreasonably slow evaluation process that drives SMEs to bankruptcy runs counter to the principles of the EU. Without EU coordination and harmonized criteria for evidence, companies are suffering unnecessary economic damage.
References
[1] European Union, Regulation (EU) 2015/2283 on novel foods, https://eur-lex.europa.eu/legal-content/NL/TXT/?uri=CELEX:32015R2283, accessed: 09/07/2026.
[2] For plants, categories 4, 7, and 10 are particularly relevant:
iv) foods consisting of, isolated from, or produced from plants or parts of plants
vii) foods resulting from a production process that was not used in the Union prior to May 15, 1997, in the context of food production, and that causes significant changes in the composition or structure of a food, affecting its nutritional value, the way it is metabolized, or its content of undesirable substances;
x) foods that, prior to May 15, 1997, were used in the Union exclusively in dietary supplements, when they are intended for use in foods other than dietary supplements as defined in Article 2(a) of Directive 2002/46/EC.”
[3] European Commission, Directive 2002/46/EC of the European Parliament and of the Council of June 10, 2002, on the approximation of the laws of the Member States relating to food supplements, https://eur-lex.europa.eu/legal-content/NL/TXT/HTML/?uri=CELEX:02002L0046-20240717, accessed: 09/07/2026.
[4] European Commission, Regulation (EU) 2015/2283 of the European Parliament and of the Council of November 25, 2015, on novel foods, https://eur-lex.europa.eu/legal-content/NL/TXT/?uri=CELEX%3A02015R2283-20210327, accessed: 09/07/2026.
[5] European Commission, Implementing Regulation (EU) 2018/456, consultation procedure for novel food status, https://eur-lex.europa.eu/legal-content/NL/TXT/HTML/?uri=CELEX:32018R0456, accessed: 09/07/2026.
[6] Federal Public Service Health, Royal Decree concerning the manufacture of and trade in foodstuffs composed of or containing plants or plant preparations, https://www.health.belgium.be/nl/organisatie-beleid/regelgeving-beleidsdocumenten/koninklijk-besluit-31-augustus-2021, accessed: 09/07/2026.
[7] Food Law Consult, “Botanicals Not Novel in Food Supplements,” https://foodlawconsult.com/2026/06/05/botanicals-not-novel-in-supplements/, accessed: 01/09/2026.
[8] European Commission, Novel Food Status Catalog, https://food.ec.europa.eu/food-safety/novel-food/novel-food-status-catalogue_en, Accessed: September 1, 2026

